Advertisement

Besondere Aspekte in der Versorgung alter und geriatrischer Patienten mit Gehirntumoren

  • Frank A. Giordano
  • Frederik Wenz
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Gehirnmetasten, Meningeome und maligen Gliome stellen Hirntumore mit Inzidenzgipfel im Senium dar. Oftmals muss sowohl die Tumorbehandlung als auch die Supportivtherapie bei geriatrischen Patienten individualisiert erfolgen. Insbesondere bei Metastasen muss sich die Therapieform nach definierten Kriterien aus Allgemeinzustand, Tumorentität, extrakranieller Tumoraktivität und Komorbiditäten richten. Für Meningeome sollte zwingend eine longitudinale Wachstumskinetik ermittelt werden und in eine Risiko-Nutzen-Bewertung einfließen. Bei den malignen Gliomen, den häufigsten primären Hirntumoren profitieren geriatrische Patienten auch von einer multimodalen Therapie in der Erst- und Zweitlinie.

Literatur

  1. Arif H, Buchsbaum R, Pierro J, Whalen M, Sims J, Resor SR Jr et al (2010) Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch Neurol 67:408–415CrossRefPubMedGoogle Scholar
  2. Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L, Mazzocchi V et al (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512–3518CrossRefPubMedGoogle Scholar
  3. Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y et al (2014) A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 88:130–136CrossRefPubMedPubMedCentralGoogle Scholar
  4. Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2:1460CrossRefPubMedGoogle Scholar
  5. Caroli M, Locatelli M, Prada F, Beretta F, Martinelli-Boneschi F, Campanella R et al (2005) Surgery for intracranial meningiomas in the elderly: a clinical-radiological grading system as a predictor of outcome. J Neurosurg 102:290–294CrossRefPubMedGoogle Scholar
  6. Chaichana KL, Pendleton C, Jackson C, Martinez-Gutierrez JC, Diaz-Stransky A, Aguayo J et al (2013) Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35:206–211CrossRefPubMedGoogle Scholar
  7. Chamberlain MC (2011) Bevacizumab for the treatment of recurrent glioblastoma. Clin Med Insights Oncol 5:117–129CrossRefPubMedPubMedCentralGoogle Scholar
  8. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ et al (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710CrossRefPubMedGoogle Scholar
  9. Gallego Perez-Larraya J, Delattre JY (2012) Treating glioblastoma in the elderly. CNS Oncol 1:193–201CrossRefPubMedGoogle Scholar
  10. Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A (2003) Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53:1028–1034; discussion 1034–1025CrossRefPubMedGoogle Scholar
  11. Giordano FA, Welzel G, Abo-Madyan Y, Wenz F (2012) Potential toxicities of prophylactic cranial irradiation. Transl Lung Cancer Res 1:254–262PubMedPubMedCentralGoogle Scholar
  12. Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32:3810–3816CrossRefPubMedPubMedCentralGoogle Scholar
  13. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG et al (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 9:29–38CrossRefPubMedGoogle Scholar
  14. Grossman R, Mukherjee D, Chang DC, Purtell M, Lim M, Brem H et al (2011) Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors. Ann Surg Oncol 18:521–528CrossRefPubMedGoogle Scholar
  15. Harth S, Abo-Madyan Y, Zheng L, Siebenlist K, Herskind C, Wenz F et al (2013) Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol 109:152CrossRefPubMedGoogle Scholar
  16. Horton J, Baxter DH, Olson KB (1971) The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 111:334–336CrossRefPubMedGoogle Scholar
  17. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535CrossRefPubMedGoogle Scholar
  18. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141CrossRefPubMedGoogle Scholar
  19. Kondziolka D, Mathieu D, Lunsford LD, Martin JJ, Madhok R, Niranjan A et al (2008) Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62:53–58; discussion 58–60CrossRefPubMedGoogle Scholar
  20. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803CrossRefPubMedGoogle Scholar
  21. Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, Wick W et al (2013) Optimal management of elderly patients with glioblastoma. Cancer Treat Rev 39:350–357CrossRefPubMedGoogle Scholar
  22. Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr et al (2011) Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 81:623–630CrossRefPubMedGoogle Scholar
  23. Malmstrom A, Gronberg BH, Marosi C, Stupp R, Frappaz D, Schultz H et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916–926CrossRefPubMedGoogle Scholar
  24. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463–469; discussion 469–470CrossRefPubMedGoogle Scholar
  25. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M et al (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88:97–103CrossRefPubMedGoogle Scholar
  26. Minniti G, Esposito V, Clarke E, Scaringi C, Bozzao A, Lanzetta G et al (2013) Stereotactic radiosurgery in elderly patients with brain metastases. J Neurooncol 111:319–325CrossRefPubMedGoogle Scholar
  27. Nicolato A, Foroni R, Alessandrini F, Maluta S, Bricolo A, Gerosa M (2002) The role of Gamma Knife radiosurgery in the management of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 53:992–1000CrossRefPubMedGoogle Scholar
  28. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28:3838–3843CrossRefPubMedPubMedCentralGoogle Scholar
  29. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489CrossRefPubMedGoogle Scholar
  30. Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B et al (2009) Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 92:185–191CrossRefPubMedGoogle Scholar
  31. Perry JR, Laperriere N, O’Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP (2017) Trial Investigators. Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med. Mar 16;376(11):1027–1037Google Scholar
  32. Pietila TA, Stendel R, Hassler WE, Heimberger C, Ramsbacher J, Brock M (1999) Brain tumor surgery in geriatric patients: a critical analysis in 44 patients over 80 years. Surg Neurol 52:259–263; discussion 263–254CrossRefPubMedGoogle Scholar
  33. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579–592PubMedGoogle Scholar
  34. Roa W, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D et al (2015) International atomic energy agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33:4145CrossRefPubMedGoogle Scholar
  35. Robert-Ebadi H, Le Gal G, Righini M (2009) Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging 4:165–177PubMedPubMedCentralGoogle Scholar
  36. Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M et al (2015) Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91:710–717CrossRefPubMedGoogle Scholar
  37. Socha J, Kepka L, Ghosh S, Roa W, Kumar N, Sinaika V et al (2016) Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients. J Neurooncol 126:493–498CrossRefPubMedGoogle Scholar
  38. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72CrossRefPubMedGoogle Scholar
  39. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425CrossRefPubMedGoogle Scholar
  40. Tatsuno I, Sugiyama T, Suzuki S, Yoshida T, Tanaka T, Sueishi M et al (2009) Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases. J Clin Endocrinol Metab 94:1671–1677CrossRefPubMedGoogle Scholar
  41. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2:210–225CrossRefPubMedPubMedCentralGoogle Scholar
  42. Vordermark D, Kolbl O, Ruprecht K, Vince GH, Bratengeier K, Flentje M (2005) Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer 5:55CrossRefPubMedPubMedCentralGoogle Scholar
  43. Waterhouse E, Towne A (2005) Seizures in the elderly: nuances in presentation and treatment. Cleve Clin J Med 72(Suppl 3):S26–S37CrossRefPubMedGoogle Scholar
  44. Welzel G, Gehweiler J, Brehmer S, Appelt JU, von Deimling A, Seiz-Rosenhagen M et al (2015) Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis. J Neurooncol 124:265–273CrossRefPubMedGoogle Scholar
  45. Wick W, Brandes AA, Gorlia T, Bendszus M, Sahm F, Taal W et al (2016). EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a glioblastoma. J Clin Oncol 34 (suppl; abstr 2001)Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Strahlentherapie und RadioonkologieUniversitätsmedizin MannheimMannheimDeutschland

Section editors and affiliations

  • Nicolai Härtel
    • 1
  1. 1.Interdisziplinäres TumorzentrumUniversitätsmedizin MannheimMannheimDeutschland

Personalised recommendations